These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 30223310)

  • 21. [The therapy of systemic lupus erythematosus].
    Ochsendorf FR; Runne U
    Dtsch Med Wochenschr; 1997 Jul; 122(27):877. PubMed ID: 9280702
    [No Abstract]   [Full Text] [Related]  

  • 22. Dosage of antimalarial drugs for children with juvenile rheumatoid arthritis and systemic lupus erythematosus. A clinical study with determination of serum concentrations of chloroquine and hydroxychloroquine.
    Laaksonen AL; Koskiahde V; Juva K
    Scand J Rheumatol; 1974; 3(2):103-8. PubMed ID: 4608161
    [No Abstract]   [Full Text] [Related]  

  • 23. [The everyday clinician. A wolf in sheep's clothing].
    Théophile
    Rev Med Brux; 2011; 32(5):490. PubMed ID: 22165530
    [No Abstract]   [Full Text] [Related]  

  • 24. [Antimalarial's retinopaty remains a current threat].
    Chiffoleau A; Guillet A; Zanlonghi X; Jolliet P
    Presse Med; 2009 Apr; 38(4):662-3. PubMed ID: 19135848
    [No Abstract]   [Full Text] [Related]  

  • 25. Ototoxicity due to hydroxychloroquine: report of two cases.
    Johansen PB; Gran JT
    Clin Exp Rheumatol; 1998; 16(4):472-4. PubMed ID: 9706431
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antimalarial therapy for lupus erythematosus: an apparent advantage of quinacrine.
    Zuehlke RL; Lillis PJ; Tice A
    Int J Dermatol; 1981; 20(1):57-61. PubMed ID: 7203769
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Complications with synthetic antimalarials].
    Huriez C; Desmons F; Gautier G; Dhellemmes
    Lille Med; 1969 Oct; 14(8):851-64. PubMed ID: 4251585
    [No Abstract]   [Full Text] [Related]  

  • 28. [Current view on chloroquine derivative treatment from rheumatologist perspective and possible ocular side effects].
    Pawlak-Buś K; Gaca-Wysocka M; Grzybowski A; Leszczyński P
    Pol Merkur Lekarski; 2016 Mar; 40(237):202-6. PubMed ID: 27088206
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hydroxychloroquine-induced acute generalized exanthematous pustulosis with positive patch-testing.
    Charfi O; Kastalli S; Sahnoun R; Lakhoua G
    Indian J Pharmacol; 2015; 47(6):693-4. PubMed ID: 26729969
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnosis of chloroquine cardiomyopathy by endomyocardial biopsy.
    Ratliff NB; Estes ML; Myles JL; Shirey EK; McMahon JT
    N Engl J Med; 1987 Jan; 316(4):191-3. PubMed ID: 3796692
    [No Abstract]   [Full Text] [Related]  

  • 31. The use of hydroxychloroquine in lupus pregnancy: the British experience.
    Khamashta MA; Buchanan NM; Hughes GR
    Lupus; 1996 Jun; 5 Suppl 1():S65-6. PubMed ID: 8803914
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Optimal use of antimalarials in treating cutaneous lupus erythematosus.
    Wozniacka A; McCauliffe DP
    Am J Clin Dermatol; 2005; 6(1):1-11. PubMed ID: 15675885
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antimalarial-Induced Cardiomyopathy Resembles Fabry Disease on Cardiac MRI.
    Hanneman K; Alberdi HV; Karur GR; Tselios K; Harvey PJ; Gladman DD; Akhtari S; Osuntokun T; Wald RM; Thavendiranathan P; Butany J; Urowitz MB
    JACC Cardiovasc Imaging; 2020 Mar; 13(3):879-881. PubMed ID: 31734202
    [No Abstract]   [Full Text] [Related]  

  • 34. Relapsed hydroxychloroquine induced thrombocytopenia in a systemic lupus erythematosus patient.
    Antón Vázquez V; Pascual L; Corominas H; Giménez Torrecilla I
    Reumatol Clin; 2017; 13(5):294-296. PubMed ID: 27263963
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Quinacrine in the treatment of cutaneous lupus erythematosus: practical aspects and a case series].
    González-Sixto B; García-Doval I; Oliveira R; Posada C; García-Cruz MA; Cruces M
    Actas Dermosifiliogr; 2010; 101(1):54-8. PubMed ID: 20109393
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cutaneous Adverse Drug Reactions with Antimalarials and Allergological Skin Tests.
    Soria A; Barbaud A; Assier H; Avenel-Audran M; Tétart F; Raison-Peyron N; Amarger S; Girardin P; Francès C;
    Dermatology; 2015; 231(4):353-9. PubMed ID: 26457932
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Chloroquine and hydroxychloroquine dosage in juvenile rheumatoid arthritis].
    Laaksonen AL; Koskiahde V; Juva K
    Duodecim; 1974; 90(2):125-31. PubMed ID: 4848261
    [No Abstract]   [Full Text] [Related]  

  • 38. [Antimalarial drug retinopathy].
    Guiot A; Couturier M; Tebib JG; Abouaf L; Coury F
    Rev Med Interne; 2018 May; 39(5):364-368. PubMed ID: 29496271
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Erythema annulare centrifugum due to hydroxychloroquine sulfate and chloroquine sulfate.
    Ashurst PJ
    Arch Dermatol; 1967 Jan; 95(1):37-9. PubMed ID: 6016304
    [No Abstract]   [Full Text] [Related]  

  • 40. Comment on 'Baseline use of hydroxychloroquine in systemic lupus erythematosus does not preclude SARS-CoV-2 infection and severe COVID-19' by Konig
    Sbidian E; Penso L; Herlemont P; Botton J; Baricault B; Semenzato L; Drouin J; Weill A; Dray-Spira R; Zureik M
    Ann Rheum Dis; 2023 May; 82(5):e117. PubMed ID: 32859610
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.